Is the price fair?
What RDY's price assumes
Dr. Reddy's Laboratories Limited has no trailing P/E on file, so the price is measured against sales instead: 0.01× revenue.
0.01
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.03
Price / book · as of 2025-FY
- EV / sales
- 0.00
EV / sales
Details›
- Price / book2025-FY
- 0.03
- EV / EBIT2025-FY
- 0.02
- EV / sales2025-FY
- 0.00
- Market capitalisation
- $12.7B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers - Specialty & Generic
Ranks #6 of 29 by Smart Score